Bayer Eyes New Areas For Collaborative Singapore Research
This article was originally published in PharmAsia News
Executive Summary
Bayer HealthCare is expanding its spread of research collaborations in Singapore into new therapeutic areas, tapping local academic and other institutions to assist with drug and biomarker development and commercialization.